Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 1Phase 2 1

Status

Completed 5

Sponsor Class

OTHER 5

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 4Tumor-Agnostic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 105Leukemia 65Burkitt Lymphoma 26Lymphoma 18Leukemia, Biphenotypic, Acute 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Promyelocytic, Acute 7Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasm, Residual 5Leukemia, Myeloid, Acute 5Down Syndrome 4Neoplasms 3Leukemia, T-Cell 3Dendritic Cell Sarcoma, Interdigitating 3Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Glioblastoma 2Thrombocytopenia 1Rare Diseases 1Philadelphia Chromosome 1Ovarian Neoplasms 1Oligodendroglioma 1Neutropenia 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Mucositis 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1

Interventions

Cyclophosphamide 22blinatumomab 18Cytarabine 15fludarabine 13Azacitidine 12venetoclax 10fludarabine phosphate 10Rituximab 8Lenalidomide 7Dexamethasone 7Methotrexate 6Daunorubicin 6Mercaptopurine 5daratumumab 4Whole-Body Irradiation 4Vincristine 4Melphalan 4Idarubicin 4Etoposide 4Busulfan 4pembrolizumab 3obinutuzumab 3Radiotherapy 3Maintenance 3Immunotherapy, Adoptive 3Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Drug Therapy 3Cladribine 3Asparaginase 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Neoplasm, Residual × Mercaptopurine × Clear all
NCT00198991 2022-08-18

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

Goethe University

Phase 4 Completed
1,883 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02067143 2021-09-08

LAL1913

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase 2 Completed
204 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasm, Residual

NCT00816049 2017-04-21

ALL2008con

Rigshospitalet, Denmark

Phase 3 Completed
775 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00526175 2016-01-20

LAL-BR/2001: Study Treatment to Low Risk ALL

PETHEMA Foundation

Phase 4 Completed
150 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00199004 2010-08-23

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

Johann Wolfgang Goethe University Hospital

Phase 4 Completed
60 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡